Iconic Labs PLC

("Iconic" or the "Company")

EHGOSF Subscribes for a £150,000 Fourth Tranche Under £ 3million Financing Facility

Iconic Labs PLC (LSE: ICON) announces that. the European High Growth Opportunities Securitization Fund ("EHGOSF") has subscribed for a £150,000 fourth tranche of convertible notes under the £3million financing facility (the "Facility") that was entered into on 28 September 2022. This subscription takes the total subscribed under the Facility to £700,000.

In exchange, Iconic will issue 150 convertible notes to EHGOSF along with 468,750,000 warrants with an exercise price of £0.00016.

The funds under this fourth tranche shall be used to meet Iconic's obligations to critical and preferential creditors under the CVA and for operational purposes. 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For any further information or enquiries please contact:

[email protected]